Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.

Medicare has undergone several major changes since it launched in 1965. And now, with the passage of the Inflation Reduction Act of 2022, it's poised to change again, with several key ...

Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

Typically, retirees — just like everyone else — get just one chance a year to make modifications to their Medicare coverage ...